ANY FUNCTIONS of immune cells are initiated by
aggregation of cell-surface receptors, which by themselves lack intrinsic signaling capacity. Most trigger molecules exist as multi-subunit complexes consisting of separate ligand binding (a-chain), and signaling chains. Fc receptors play a prominent role in the immune system and have been identified by virtue of unique ligand binding chains for IgG (FcyR), IgE (FccR), and IgA (FcaR) isotypes. Most of these receptors associates with "common" signaling chains such as the Fc receptor y -and (-chains (originally identified in the FctRI, and the TClUCD3 complex, respectively' ').
Within the cytoplasmic tail of both these chains a YXXL7x-YXXL immunoreceptor tyrosine-based activation motif (ITAM) was identified to be critical for activatory funct i o n~.~.~
The class I1 low-affinity IgG receptor (FcyRII; CD32) is the most broadly distributed class of FcyR. Three different genes code for at least six isoforms with unique cell distribution and signaling capacities. All receptors represent 40-kD molecules with similar extracellular, but highly different cytoplasmic tails. The myeloid receptor FcyRIIa bears a unique ITAM, which contains 12 instead of 7 amino acid (aa) residues between the two YXXL boxes. The FcyRIIb subclass contains another unique signaling domain, a 13-aa "AENTITYSLLMHP" region, also known as immunoreceptor tyrosine-based inhibitor motif (ITIM) that has been shown essential for down-regulation of B lymphocytes""' and mast cells."
The association of different Ig receptors with the FcR ychain is critical for activatory functions including increases in tyrosine phosphorylation, and [Ca"], , phagocytosis, anti- gen presentation, and the triggering of IL-2 production.''~'4 Similarily, FcyRIIa was capable of triggering increases in tyrosine phosphorylation,"'.'' [Ca2'],y.i6 and antibody-dependent cell-mediated cytotoxicity,16 and phagocytosis,"'.''."7.'X but appeared not to stimulate production of interleukin-2 (1L-2) or antigen presentation in IIA1.6 transfectants."' In this study, we tested the role of ITAMs in triggering these two functions by using FcyRIIa cotransfected with FcR ychain, and chimeric molecules in which the ITAMs of FcyRIIa and FcR y-chain were swapped. Our data show FcyRIIa capable of functional association with FcR y-chain in IIA I .6 B cells, and identify a qualitative difference between FcyRIIa and y-chain ITAMs.
MATERIALS AND METHODS

cDNAs.
FcyRIIa-H 131 wild-type (WT) (cDNA pPW3)," FcyRlIaY48F-Y64F mutant cDNA,"' or FcyRI1a:y-ITAM chimeric cDNA were cloned into pRC-CMV vector containing a geneticin resistance gene. FcyRIIaY48F-Y64F represents a mutant molecule in which the tyrosines at aa positions 48 and 64 within the ITAM of FcyRIIa were mutated into phenylalanines."' FcyRI1a:y-ITAM represents a chimeric molecule in which the last 29 aa of the FcyRIIa cytoplasmic tail were replaced by 22 aa of the murine FcR y chain (Fig I) .
The murine FcR y-chain cDNA"' or y:IIa-ITAM cDNA was cloned into the pNUT expression vector, allowing selection o f transfectants with methotrexate (MTX"). The y:IIa-ITAM represents a chimeric molecule in which the last 22 aa of the murine ychain cytoplasmic tail were replaced by 29 aa of FcyRIIa (see Fig  1 ) . The y:Ila-ITAM and FcyRlIa chimeric cDNAs were generated by two-step overlap extension polymerase chain reactions (PCRs; primers from Isogen, Amsterdam, The Netherlands), followed by confirmation of their integrity by sequence analysis.
Cells. The FcyR-negative murine B-cell line IIA1.6, derived from the A20 B-cell lymphoma** and the murine ovalbumine (OVA)-specific T-cell hybridoma 3D0-S4.8,2' were cultured in RPMI 1640 medium supplemented with 10% heat-inactivated fetal calf serum (FCS), SO pg/mL gentamycin, HEPES, I g/L NaHCO?, and 2 mmoU L sodium pyruvate. The IL-2-dependent cell line CTLL-l6 was propagated in RPMI 1640 culture medium supplemented with 100 U/mL IL-2. IIA PC'II o n transfected 1IAl.6 cells. Two FcR y-chain-specific primers, yMPl (\ense; S'-AG(;ATCAlCTCACCC-3') and yMP2 (antisense; S'-GGTCrCI'CCCA(;CTT-3') were used encompassing nucleolitlcs 40 through 57.5 of murine y-chain. In addition, y:Ila-ITAM transcripts were detected by using y-chain---specitic pl-irner MG I and FcyRlla-spccitic primer AMP2 (antisense S'-GTTTG'I'ACT-TTAAGCAA-3') resulting in a band with a predicted size of 450 hp, cl)NA quality was confirmed by amplitication of a 345-bp [lactin hand, using specilic prirnels." f~( , f (~r~l ; J z (~t~l~}~ of (L-2 p n x k f i o n by I;cyRlla-frun.s~~~i.c~tutf h' c~c1l.s. 11.-2 production was triggered by culturing (co-)lranrfcctcd IIA I .6 cells ( I X IO"/mL) in 96-well plates coated with 1 0 0 pg/ml. human lgG ( C M , Amsterdam, The Netherlands), COI-24 hours at 37°C. Alternatively. cells wcrc incubated with MoAh AT10 culture supernatant lor 30 minutes at rootn temperature, washed, antl goat-antimouse IgGl antiserum (Southern Biotechnology; final conccntration 30 pg/mL) was added for 24 hours at 37°C. In selected experiments heat-aggregated (a) lgC2" (CLB; SO &nL) was added t o cell 5~1s-pensions. Addition of F(ab'), fragments of goat-antimctuse IgG antiscI-um ( I S pg/nll>; Southcrn Biotechnology) triggering H-cell a c t i wtlon via the B-cell receptor wa\ used a s a positive control."'" The presence of l L 2 released by IIA1.6 cells into culture supernatants was determined by culturing 
RESULTS AND DISCUSSION
FcyRIIa and FcR y-chain molecules express similar, aibcit nonidentical ITAM signaling motifs'.' in their cytoplasmic tails. To assess whether functional differences exist belween FcyRIla-antl y-chain-ITAMs, we transfected wildtype and chimeric FcyRIIa to rIA1.6 H cells. On cultured monocytes and alveolar macrophages, FcyRlla has been found to physically interact with FcR y chain." Thercfore, we cotransiected FcyRIIa or an FcyRIlaY4WY64F molecule (in which both tyrosines within Ha-[TAM were mutated into phenylalanines"') with FcK y-chain. In addition, two chimeric molecules were constructed in which the ITAMs of FcyRlIa and FcR y-chain were swapped. In the first Fig l ) , and this molecule was cotransfected with FcyRlla. All (co-)transfections were performed in the FcR-and FcR y-chain-negative R-cell line IlAl h." FcyRll expression levels of the different (CO-) transfectants were regularly checked by using CD32 MoAb AT10 (Fig 2A) . and remained stable during the course of experiments described here. The presence of y-chain and y:lla-ITAM mRNA in different transfectants was verified by RT-PCR. A 536-bp band was found in FcR y-chain cotransfectants but not in FcyRlla-and FcyRlla:y-ITAMexpressing cells (Fig 2R) . Consistent with the usage of an FcyRlla-specific 3' primer, the RT-PCR product in y:lla-ITAM cotransfectants was smaller (450 bp). cDNA quality was checked by amplifying p-actin using specific primers, yielding a 345-bp band in RT-cDNA from all cells (Fig 2R) .
FcR y-chnir~ ITAM is critical j?)r IL-2 prorl~tction o r 1 crnss-lirlkirlg FcyRIIn. FcyRlla has previously found capable of triggering increases in ICa2'li and protein tyrosine phosphorylation patterns in IIAI .6 cells, with a critical role for the Ha-ITAM.'",'" However. an increase in IIA1.6 IL-2 production could not be triggered via FcyRlla. whereas cells are able to produce IL-2 after B-cell receptor cross-linking."'," In addition. chimeric mouse FcyR molecules containing the FcR y-chain cytoplasmic tail were active in triggering IL-2 from this cell line.'' To assess whether the FcR y-chain ITAM was essential for IL-2 production, we cultured different FcyRlla (co-)transfectants in human IgGcoated plates and measured IL-2 in culture supernatants. FcyRlla-expressing IIA 1.6 cells, again, were unable to produce IL-2 in this way. However, these and other transfectants could effectively be triggered to secrete IL-2 on cross-linking of the B-cell receptor [via addition of F(ab')? fragments of goat anti-mouse antiserum: Fig 3, cross-hatched bars] . Notably, the cells expressing both FcyRlla and y-chain showed an increase in 1L-2 production on cross-linking of FcyRlla (Fig 3) . This indicated FcyRlla to functionally interact with FcR y-chain. In addition, the FcyRl1a:y-ITAM chimeric molecule proved even more effective, suggesting the FcR y-chain-ITAM to be critical for release of IL-2. This was further supported by the IL-2-producing capability of FcyRIIa-Y48F-Y64F + y-chain cotransfectant. in which the integrity of the FcyRlla-ITAM was destroyed"' (Fig 3) . FcR cross-linking of the FcyRlla + y:lla-ITAM-expressing cells was ineffective. Comparable results were obtained on incubating transfectants with CD32 MoAb ATIO, and goatantimouse lgGl for 24 hours at 37°C.
or via addition of aggregated human IgG to cell suspensions (data not shown). Cells cultured in noncoated wells, or in the absence of goatantimouse lgGl or algG served as negative controls. In combination, these data show the capacity of FcyRIla:y-ITAM to trigger cytokine release from transfected B cells, both via anti-FcyRII MoAb and immune complexes. Engagcment of the FcyRlla by Fc-domains of IgG, thus, did not appear critical for initiation of IL-2 release from transfectants.
For FcR y-chain ITAM is critical for antigen presentation via FcyRlla. The capacity of B cells to present antigens internalized via surface IgMngG is well known and plays an important role in initiation of immune responses. FcyRIIa can also internalize immune complexe~,~.'~ but its capacity to trigger antigen presentation in B cells has not been analyzed. To assess the FcyRIIa-mediated antigen presentation capacity of different transfectants, cells were incubated with increasing concentrations of rabbit IgG-ovalbumine (IgG-OVA) complexes, and OVA-specific T cells. Although FcyRIIa was capable of interacting with rabbit IgG-complexes, FcyRIIa-expressing cells proved unable to present OVA to T cells and no IL-2 could be detected (Fig 4A) . The capacity of 11A1.6 B cells to present IgG-antigen complexes internalized via Fc receptors has been well documented for mouse FcyR-y chain complexe~.~.'~ Therefore, the functional role of the FcR y-chain ITAM was tested using FcyRIIa cotransfectants and chimeric molecules. The FcyRIIa + y-chain cotransfectants were found to present antigen (Fig 4A) . IIA1.6 cells expressing FcyRIIaY48F-Y64F + y-chain were likewise capable to present internalized OVA, indicating that the integrity of IIa-ITAM not to be critical. The importance of the FcR y-chain ITAM was further evidenced by the capacity of FcyRI1a:y-ITAM chimeric molecules to present antigen (Fig 4A) . In addition, cells expressing IIa + y:IIa-ITAM were ineffective in antigen presentation. The present study shows FcyRIIa unable to mediate antigen presentation by itself. Coexpression of FcR y-chain, however, reconstituted the capacity to trigger this function (Fig 4A) . Furthermore, the existence of a functional association between FcyRIIa and FcR y-chain may underly the documented capacity of FcyRIIa on normal monocytes to present antigen.** A central role for y-chain in FcyR biologic functioning is evident from the pleiotrophic effects noted in an FcR y-chain knock-out Next we tested whether different capacities to internalize
2-
OVA-complexes underlay the observed differences between the various (co-)transfatants to present antigen. Cells were incubated with IgG-OVA complexes for 30 minutes at 4"C, washed, and further incubated for either 3 or 5 minutes at 37°C. Under these conditions, all transfectants proved capable of internalizing OVA-complexes with similar kinetics (Fig 4B) . Nontransfected, or FcyRIIbl-expressing cells (previously found unable to internalize IgG complexe~~*'~) served as controls, and were negative in this assay. These findings are consistent with previous studies showing internalization of soluble immune complexes to be independent of the integrity of ITAMs.'"~'' The molecular determinants required for uptake of soluble immune complexes, which can be mediated both by ITAM-containing FcyRIIa (Fig 4B) and FcyRIIU y-chain," as well as ITIM-containing F~yR1Ib2,~ have not been characterized yet. Previously, different patterns of phosphoproteins have been reported on cross-linking of different ITAM-containing molecules. However, it remained unclear whether these reflected qualitative rather than quantitative effects.3n.3' Evidence for qualitative differences between ITAMs has earlier been obtained for the signaling components of the B-cell receptor c o m p l e~.~.~~ For example, chimeric molecules containing the cytoplasmic region of Ig-a triggered IL-2 production in contrast to those with the Ig-p cytoplasmic domain in IIAl.6 cells. In addition, these chimeras triggered different calcium-signaling and tyrosine phosphorylation patterns." Studies by Park et a134 showed the y-chain to be more active than 6-chain in conferring phagocytic capacity to FcyRIIIa in COS cells, in support of qualitative differences between both accessory subunits. On the other hand, in a Jurkat transfection model Irving et a135 showed multiplication of ITAMs to result in quantitatively enhanced signaling ability of chimeric c-chain molecules.
The present data establish functional differences to exist between two Fc receptor ITAMs. The molecular basis for these observed functional differences between FcR ITAMs is unclear. By analogy with studies discussed above, we hypothesize that signaling components may interact differentially with the two FcR ITAMs. Interesting in this context are recent studies indicating pp72Syk protein tyrosine kinase to be essential for y-chain-ITAM mediated functions. By contrast, FcyRIIa-ITAM triggered effects proved much less VAN DEN HERIK-OUDIJK ET AL dependent on this protein tyrosine kinase.14 Identification of the specific Src-family and Syk protein tyrosine kinases interacting with the different FcR ITAMs may shed light on the observed functional differences, and is a subject of future study.
Finally, these studies show FcyRIIa not only to trigger functions via its cytoplasmic tail, but also to form functional complexes with FcR y-chain. Such multi-subunit complexes may well be essential for proper functional activity of FcyRIIa. In addition, TTAMs expressed in FcyRIIa and FcR y-chain were found to trigger qualitatively different responses. Definition of the molecular basis for the observed functional differences between these FcR signaling motifs is essential for a better understanding of the role of Ig receptors in immunity.
